UK Markets closed

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.64+0.26 (+4.08%)
As of 11:59AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close6.38
Bid6.61 x 1100
Ask6.63 x 800
Day's range6.41 - 6.65
52-week range4.42 - 12.61
Avg. volume1,960,707
Market cap482.414M
Beta (5Y monthly)0.85
PE ratio (TTM)N/A
EPS (TTM)-1.07
Earnings date11 Nov 2021 - 15 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.06
  • Globe Newswire

    AC Immune to Present at the Jefferies London Healthcare Conference

    LAUSANNE, Switzerland, Oct. 25, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company management will participate in a fireside chat and one-on-one investor meetings during the virtual portion of the Jefferies London Healthcare Conference, taking place November 18-19, 2021. During the fireside chat, Prof. Andrea Pfeifer, CEO, AC Immune SA, will discuss the Company

  • Simply Wall St.

    Shareholders in AC Immune (NASDAQ:ACIU) are in the red if they invested five years ago

    We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed. For...

  • Globe Newswire

    AC Immune CEO Andrea Pfeifer Receives First SEF.WomenAward for CEO of the Year

    LAUSANNE, Switzerland, Sept. 03, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced its Co-Founder and CEO Andrea Pfeifer has been awarded by the Swiss Economic Forum (SEF) with the SEF.WomenAward, in the category CEO of the Year, during a ceremony at the SEF meeting in Interlaken on September 2, 2021. The SEF.WomenAward recognizes women with an excellent entrep